Phase Ib venetoclax combined with bortezomib and dexamethasone in relapsed/refractory multiple myeloma.

被引：0

作者：

Moreau, Philippe

Chanan-Khan, Asher Alban Akmal

Roberts, Andrew Warwick

Agarwal, Amit

Facon, Thierry

Kumar, Shaji

Touzeau, Cyrille

Diehl, Susan

Cordero, Jaclyn

Ross, Jeremy A.

Munasinghe, Wijith

Zhu, Ming

Salem, Ahmed H.

Leverson, Joel

Maciag, Paulo Cesar

Verdugo, Maria E.

Harrison, Simon J.

机构：

[1] CHU Nantes, Hotel Dieu HME, Nantes, France

[2] Mayo Clin Florida, Jacksonville, FL USA

[3] Royal Melbourne Hosp, Parkville, Vic, Australia

[4] Univ Arizona, Tucson, AZ USA

[5] CHRU Lille, Hop Claude Huriez, Lille, France

[6] Mayo Clin, Div Hematol, Rochester, MN USA

[7] AbbVie Inc, N Chicago, IL USA

[8] Peter MacCallum Canc Ctr, East Melbourne, Vic, Australia

来源：

关键词：

D O I：

10.1200/JCO.2016.34.15_supp1.8011

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

8011

引用

页数：2